News | News By Subject | News by Disease News By Date | Search News

Hormone replacement (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Lipocine (LPCN) Shares Slump as FDA Does Not Approve NDA for Testosterone Drug LPCN 1021     6/29/2016
Embattled Acerus (TRLPF) Loses U.S. Distribution Deal for Natesto With Endo International (ENDP)     12/31/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
TherapeuticsMD, Inc.  (TXMD) Looking At Lower Cash Burn, Higher Upside From Promising HRT Therapies: Cowen     11/7/2014
Trimel Pharmaceuticals (Formerly Known As Trimel BioPharma) (TRL.TO) Rises On FDA Approval For Natesto™ Nasal Gel     5/29/2014
Pfizer Inc. (PFE) Pursues Early Approval For Breast Cancer Drug     5/19/2014
FDA Approves Endo Pharmaceuticals (ENDP)'s Testosterone Drug AVEED™     3/6/2014
FDA Questions Credibility of Repros Therapeutics Inc. (RPRX)'s Androxal® Data     10/24/2013
Lipocine Inc. Makes Reverse Merger Move and Snags $38 Million to Advance its Oral Testosterone Product Portfolio     7/26/2013
Is AbbVie (ABBV) Already Making a Recall?     1/16/2013
Amgen (AMGN)'s Prolia(R) (Denosumab) Phase 2 Extension Study Showed Continued Increase in Bone Mineral Density Over Eight Years of Treatment     9/19/2011
Deceptive Trade Suit Against Drug Makers Including Wyeth Pharmaceuticals (New Jersey) (WYE) Pfizer Inc. (PFE) and Pharmacia & Upjohn (Merged to form Pharmacia Corp) to Proceed     7/29/2011
Pfizer Inc. (PFE) Faces Trials in 200 Suits Over Hormone-Drugs     6/18/2010

News from Around the Web
Family Stunts Disabled Daughter's Growth To Expand Her World     10/26/2015
Researchers Identify Why Dopamine Replacement Therapy has a Paradoxical Effect on Cognition, University Of Montreal Study     6/15/2011
Estrogen Treatment With No Side Effects in Sight, University of Gothenburg Researchers Find     4/12/2011
Hormone Linked to Absence of Periods in Women With Low Body Fat, Beth Israel Deaconess Medical Center Study     4/11/2011
Progesterone Gel Reduces Risk of Early Preterm Birth, National Institute of Child Health and Human Development Study     4/7/2011
Risks of Estrogen Hormone Therapy Seen to Fade After Treatment Ends, Fred Hutchinson Cancer Research Center Study Finds     4/7/2011
Leptin Restores Fertility, May Improve Bone Health in Lean Women; Treatment Could Help Athletes, Women With Eating Disorders, Beth Israel Deaconess Medical Center Study     4/6/2011
Combination of Two Hormones Increases Height in Girls with Turner Syndrome, Thomas Jefferson University Study     3/31/2011
Illegal Use of Human Growth Hormone Common Among Young Male Weightlifters, Mclean Hospital and Harvard Medical School Study     1/21/2011
Why Hormone Mix Raises Cancer Risk, Michigan State University Study     1/20/2011
Grape Ingredient Resveratrol Increases Beneficial Fat Hormone, University of Texas Health Science Center Study     1/11/2011
Testosterone Could Boost Health of Heart Failure Patients, University of Alberta Study     10/6/2010
Nasal Spray Turns Jerks into Nice Guys, Mount Sinai School of Medicine and Columbia University Study     9/29/2010
New Study Links Breast Cancer to Hormone Therapy, Canadian Cancer Society Reveals     9/24/2010
Hormone Replacement May Not Save Women's Muscle, Women's Health Initiative (WHI) and Arizona Cancer Center Study     8/23/2010

Press Releases
Ammonett Pharma Receives Positive Opinion From European Orphan Medicinal Products Committee For MK-0677 For Treatment Of Pediatric Growth Hormone Deficiency     5/23/2017
Custopharm Acquires Two ANDA Pharmaceutical Products From Perrigo (PRGO)     1/4/2017
Repros Therapeutics (RPRX) Announces Submission Of MAA To The EMA For Enclomiphene In The Treatment Of Secondary Hypogonadism     9/13/2016
Ascendis Pharma A/S To Present At The UBS Global Healthcare Conference On May 23, 2016     5/18/2016
Transition Therapeutics (TTH.TO) Announces Second Quarter Fiscal 2016 Financial Results     2/10/2016
Ascendis Pharma A/S To Present At The Leerink Partners Global Healthcare Conference     2/4/2016
Embattled Acerus (TRLPF) Loses U.S. Distribution Deal for Natesto With Endo International (ENDP)     12/31/2015
Juniper Pharma (JNP) Adds Three New Products To Its Proprietary Pipeline     11/13/2015
Versartis, Inc. (VSAR) To Hold Conference Call To Discuss Six Month VRS-317 Phase 2a VERTICAL Clinical Trial Results     6/9/2014
Repros Therapeutics Inc. (RPRX) Fully Enrolls Second Previously Announced Head To Head Study Of Androxal® Versus The Leading Topical Testosterone Gel     5/13/2014
Antares Pharma, Inc. (ATRS) Announces Positive Results From The VIBEX Quickshot Pharmacokinetic Study In Testosterone Deficient Men     2/20/2014
Noven Pharmaceuticals Inc. Release: First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S. Pharmacies     11/5/2013
Versartis, Inc. Receives Orphan Drug Status for Its Novel Long-Acting Growth Hormone Treatment From European Commission (EC)     9/13/2013
Versartis, Inc. Presents Positive Results From Its First Pediatric Clinical Study of Novel Long-Acting Growth Hormone Treatment at ENDO Annual Meeting     6/17/2013
Evotec AG (EVTG.F): New Hormone to Treat Diabetes Published in "Cell"     4/26/2013